Approval · Notice of Compliance 10778 · 2009
AGRYLIN: Notice of Compliance 10778
Issued November 12, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10778
- Date
- November 12, 2009
- Company
- Shire Canada IncLaval, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph with respect to pharmacokinetic differences in the elderly compared to the non-elderly with anagrelide exposure
- Therapeutic class
- Platelet-reducing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AGRYLIN | Not yet assigned | — |
Medicinal ingredients
- ANAGRELIDE HYDROCHLORIDE 0.5 MG per CAP